Welcome to ATMP Sweden!
ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Robert Langer to present at ATMP Sweden 2021
MIT, Moderna and Bill Gates, leading the world in mRNA gene delivery medicinesRead article
Sahlgrenska progresses TILs manufacturing for clinical trials
An important step for patients with metastatic uveal melanoma.Read article
ATMP Sweden newsletter June 2021
Including launch of our ATMP Introductory course!Read article
Who are we?
The ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu. Other Swedish ATMP specific national networks within the ATMP Sweden umbrella include NextGenNK focused on cost effective development of Natural Killer (NK) cell based therapies and SWECARNET, Sweden’s network for clinical use of CAR T cells.
Conferences & events
ATMP: From research to GMP
Ta del av vad man behöver tänka på när man tar en experimentell process till GMP.Read more
ATMP Sweden 2021
Organizer: ATMP Sweden
Learnings from 'gene delivery' COVID vaccines relevant to ATMPRead more
INTRODUCTION TO ATMP COURSE
Organizer: ATMP Innovation Milieu
AVAILABLE from the 9th of June 2021! Learn the basics of Advanced Therapy Medicinal Products.Read more